Study Claims Ozempic Lowers Biological Age | PharmExec
Study Claims Ozempic Lowers Biological Age Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
The Turkish glees, language barrier
The Turkish Experience: A Language Barrier In traditional Botswana, a Setswana maxim states: “Go tsamaya ke go bona (the exper…
OPPO, Ballet Philippines to promote Filipino Artistry with new partnership
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, coinciding …
Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Banks’ stampede for deposits to intensify
Banks' Stampede for Deposits to Intensify The competition for deposits among local commercial banks is expected to escalate, as the centra…
This ‘minor’ bird flu strain has potential to spark human pandemic
Bird Flu Strain H9N2: A Potential Pandemic Threat A 'minor' bird flu strain, H9N2, has shown potential to spark a human pandemic, despite …
Here’s why Utah’s Olympic organizers are in NYC this week
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are in New York City to show support for American athletes competing …
Community pharmacies and BioPharma: Advancing whole-patient care together
Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together The healthcare landscape has become increasingly complex, with a…
Top 10 at 11: Healthcare and tech lead ASX lower as CSL and Wisetech bleed - Stockhead
ASX Market Update The Australian stock market is experiencing a decline, led by heavy falls in the healthcare and tech sectors, despite se…
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, Inc. announced positive results from the Phase 2 …
How to Navigate Complex Injury Cases Efficiently - GigWise
Navigating Complex Injury Cases Efficiently Dealing with a serious injury case can be stressful and confusing, but there are steps you can…